Cargando…

OSW‐1 inhibits tumor growth and metastasis by NFATc2 on triple‐negative breast cancer

OSW‐1 is a natural compound extracted from the bulbs of Ornithogalum saundersiae in 1992. It has been shown strong antitumor activities in various cancer cells. However, the effects of OSW‐1 on tumor growth and metastasis in breast cancer are still poorly understood. In our research, we showed that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Xiaorong, Li, Yumei, Li, Jun, Yin, Yongmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402832/ https://www.ncbi.nlm.nih.gov/pubmed/32515123 http://dx.doi.org/10.1002/cam4.3196

Ejemplares similares

Identification of tRNA‐derived small noncoding RNAs as potential biomarkers for prediction of recurrence in triple‐negative breast cancer
por: Feng, Wanting, et al.
Publicado: (2018)

Fangjihuangqi Decoction inhibits MDA‐MB‐231 cell invasion in vitro and decreases tumor growth and metastasis in triple‐negative breast cancer xenografts tumor zebrafish model
por: Guo, Yubo, et al.
Publicado: (2020)

Osteoprotegerin expression in triple-negative breast cancer cells promotes metastasis
por: Weichhaus, Michael, et al.
Publicado: (2014)

LIPG signaling promotes tumor initiation and metastasis of human basal-like triple-negative breast cancer
por: Lo, Pang-Kuo, et al.
Publicado: (2018)

NFATc2 enhances tumor-initiating phenotypes through the NFATc2/SOX2/ALDH axis in lung adenocarcinoma
por: Xiao, Zhi-Jie, et al.
Publicado: (2017)

The role of EMT-related lncRNA in the process of triple-negative breast cancer metastasis
por: Zhang, Haomeng, et al.
Publicado: (2021)

EHD2 overexpression promotes tumorigenesis and metastasis in triple-negative breast cancer by regulating store-operated calcium entry
por: Luan, Haitao, et al.
Publicado: (2023)

Fascin‐1 as a novel diagnostic marker of triple‐negative breast cancer
por: Wang, Chao‐Qun, et al.
Publicado: (2016)

DYRK1A activates NFATC1 to increase glioblastoma migration
por: Liu, Heng, et al.
Publicado: (2021)

A useful strategy for synthesis of the disaccharide of OSW-1
por: Wang, Bin, et al.
Publicado: (2023)

Hybrid liposomes inhibit tumor growth and lung metastasis of murine osteosarcoma cells
por: Kitajima, Hideki, et al.
Publicado: (2013)

Protein arginine methyltransferase 5: A novel therapeutic target for triple‐negative breast cancers
por: Vinet, Mathilde, et al.
Publicado: (2019)

ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer
por: Fang, Wentong, et al.
Publicado: (2021)

Effects of human arylamine N-acetyltransferase I knockdown in triple-negative breast cancer cell lines
por: Tiang, Jacky M, et al.
Publicado: (2015)

NFATc1 is a tumor suppressor in hepatocellular carcinoma and induces tumor cell apoptosis by activating the FasL‐mediated extrinsic signaling pathway
por: Xu, Sanrong, et al.
Publicado: (2018)

Impact of histotypes on preferential organ‐specific metastasis in triple‐negative breast cancer
por: Li, Yaming, et al.
Publicado: (2019)

Asperolide A prevents bone metastatic breast cancer via the PI3K/AKT/mTOR/c‐Fos/NFATc1 signaling pathway
por: Jiang, Wenli, et al.
Publicado: (2020)

Development and characterization of two human triple‐negative breast cancer cell lines with highly tumorigenic and metastatic capabilities
por: Su, Yanrong, et al.
Publicado: (2016)

RECQL5 plays an essential role in maintaining genome stability and viability of triple‐negative breast cancer cells
por: Peng, Jin, et al.
Publicado: (2019)

Two activating mutations of MPL in triple‐negative myeloproliferative neoplasms
por: Xie, Juan, et al.
Publicado: (2019)

Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression
por: Siddharth, Sumit, et al.
Publicado: (2021)

MiR-940 Inhibited Cell Growth and Migration in Triple-Negative Breast Cancer
por: Hou, Lingmi, et al.
Publicado: (2016)

The testis protein ZNF165 is a SMAD3 cofactor that coordinates oncogenic TGFβ signaling in triple-negative breast cancer
por: Gibbs, Zane A, et al.
Publicado: (2020)

Role of ABCB1 in mediating chemoresistance of triple-negative breast cancers
por: Abd El-Aziz, Yomna S., et al.
Publicado: (2021)

Elucidation of OSW-1-Induced Stress Responses in Neuro2a Cells
por: Oh-hashi, Kentaro, et al.
Publicado: (2023)

Human WDR5 promotes breast cancer growth and metastasis via KMT2-independent translation regulation
por: Cai, Wesley L, et al.
Publicado: (2022)

The hedgehog pathway in triple‐negative breast cancer
por: Habib, Joyce G., et al.
Publicado: (2016)

Integrin β4 promotes DNA damage-related drug resistance in triple-negative breast cancer via TNFAIP2/IQGAP1/RAC1
por: Fang, Huan, et al.
Publicado: (2023)

Exosome‐mediated delivery of miR‐204‐5p inhibits tumor growth and chemoresistance
por: Yao, Surui, et al.
Publicado: (2020)

Mammary tumor growth and metastasis are reduced in c‐Kit mutant Sash mice
por: He, Licai, et al.
Publicado: (2016)

Inhibition of breast cancer cell growth by methyl pyropheophenylchlorin photodynamic therapy is mediated though endoplasmic reticulum stress‐induced autophagy in vitro and vivo
por: Zhu, Jiang, et al.
Publicado: (2018)

Anticancer Effects and Mechanisms of OSW-1 Isolated From Ornithogalum saundersiae: A Review
por: Zhan, Zhixin, et al.
Publicado: (2021)

Pamiparib dose escalation in Chinese patients with non‐mucinous high‐grade ovarian cancer or advanced triple‐negative breast cancer
por: Xu, Binghe, et al.
Publicado: (2020)

Lamin B2 promotes the progression of triple negative breast cancer via mediating cell proliferation and apoptosis
por: Zhao, Cui-Cui, et al.
Publicado: (2021)

LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR‐219a‐5p
por: Wang, Lihong, et al.
Publicado: (2019)

DDR2 controls breast tumor stiffness and metastasis by regulating integrin mediated mechanotransduction in CAFs
por: Bayer, Samantha VH, et al.
Publicado: (2019)

LRP8 is overexpressed in estrogen‐negative breast cancers and a potential target for these tumors
por: Maire, Virginie, et al.
Publicado: (2018)

Transformable Neuropeptide Prodrug with Tumor Microenvironment Responsiveness for Tumor Growth and Metastasis Inhibition of Triple‐Negative Breast Cancer
por: Cao, Yi, et al.
Publicado: (2023)

Modulation of CXCL-8 expression in human melanoma cells regulates tumor growth, angiogenesis, invasion, and metastasis
por: Wu, Sheng, et al.
Publicado: (2012)

Nerve growth factor receptor negates the tumor suppressor p53 as a feedback regulator
por: Zhou, Xiang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tofabfk6ff3pagtrnnv9e2g0s5